28195652|t|Identification of the anti-mycobacterial functional properties of piperidinol derivatives
28195652|a|Tuberculosis (TB) remains a major global health threat and is now the leading cause of death from a single infectious agent worldwide. The current TB drug regimen is inadequate, and new anti-tubercular agents are urgently required to be able to successfully combat the increasing prevalence of drug-resistant TB. The purpose of this study was to investigate a piperidinol compound derivative that is highly active against the Mycobacterium tuberculosis bacillus. The antibacterial properties of the piperidinol compound and its corresponding bis-Mannich base analogue were evaluated against M. smegmatis and Gram-negative organisms. Cytotoxicity studies were undertaken in order to determine the selectivity index for these compounds. Spontaneous resistant mutants of M. smegmatis were generated against the piperidinol and corresponding bis-Mannich base lead derivatives and whole genome sequencing employed to determine the genetic modifications that lead to selection pressure in the presence of these compounds. The piperidinol and the bis-Mannich base analogue were found to be selective for mycobacteria and rapidly kill this organism with a cytotoxicity selectivity index for mycobacteria of >30-fold. Whole genome sequencing of M. smegmatis strains resistant to the lead compounds led to the identification of a number of single nucleotide polymorphisms indicating multiple targets. Our results indicate that the piperidinol moiety represents an attractive compound class in the pursuit of novel anti-tubercular agents.
28195652	22	40	anti-mycobacterial	T103	UMLS:C0360390
28195652	66	89	piperidinol derivatives	T103	UMLS:C1254351
28195652	90	102	Tuberculosis	T038	UMLS:C0041296
28195652	104	106	TB	T038	UMLS:C0041296
28195652	168	182	cause of death	T033	UMLS:C0007465
28195652	237	239	TB	T038	UMLS:C0041296
28195652	240	244	drug	T103	UMLS:C0013227
28195652	245	252	regimen	T058	UMLS:C0040808
28195652	276	298	anti-tubercular agents	T103	UMLS:C1254351
28195652	384	401	drug-resistant TB	T038	UMLS:C0206525
28195652	423	428	study	T062	UMLS:C2603343
28195652	450	481	piperidinol compound derivative	T103	UMLS:C1254351
28195652	516	542	Mycobacterium tuberculosis	T007	UMLS:C0026926
28195652	543	551	bacillus	T007	UMLS:C0004587
28195652	557	570	antibacterial	T103	UMLS:C0279516
28195652	589	609	piperidinol compound	T103	UMLS:C1254351
28195652	632	648	bis-Mannich base	T103	UMLS:C0024728
28195652	649	657	analogue	T103	UMLS:C0243071
28195652	663	672	evaluated	T058	UMLS:C0220825
28195652	681	693	M. smegmatis	T007	UMLS:C0317761
28195652	698	721	Gram-negative organisms	T007	UMLS:C0018150
28195652	723	735	Cytotoxicity	T038	UMLS:C0596402
28195652	736	743	studies	T062	UMLS:C2603343
28195652	786	803	selectivity index	T170	UMLS:C0918012
28195652	814	823	compounds	T103	UMLS:C1254351
28195652	847	854	mutants	T038	UMLS:C0596988
28195652	858	870	M. smegmatis	T007	UMLS:C0317761
28195652	898	909	piperidinol	T103	UMLS:C1254351
28195652	928	961	bis-Mannich base lead derivatives	T103	UMLS:C1254351
28195652	1016	1037	genetic modifications	T062	UMLS:C4277689
28195652	1095	1104	compounds	T103	UMLS:C1254351
28195652	1110	1121	piperidinol	T103	UMLS:C1254351
28195652	1130	1155	bis-Mannich base analogue	T103	UMLS:C1254351
28195652	1187	1199	mycobacteria	T007	UMLS:C0026912
28195652	1238	1250	cytotoxicity	T038	UMLS:C0596402
28195652	1251	1268	selectivity index	T170	UMLS:C0918012
28195652	1273	1285	mycobacteria	T007	UMLS:C0026912
28195652	1326	1338	M. smegmatis	T007	UMLS:C0317761
28195652	1364	1378	lead compounds	T103	UMLS:C1254351
28195652	1420	1451	single nucleotide polymorphisms	T082	UMLS:C0752046
28195652	1511	1529	piperidinol moiety	T103	UMLS:C1254351
28195652	1555	1569	compound class	T103	UMLS:C1254351
28195652	1594	1616	anti-tubercular agents	T103	UMLS:C1254351